Evidence map›Paper›PMID 34682970›Full record

ArticleHealthcare (Basel, Switzerland)2021

A Comprehensive Examination of Severely Ill ME/CFS Patients.

Chia-Jung Chang, Li-Yuan Hung, Andreas M Kogelnik, David Kaufman, Raeka S Aiyar, Angela M Chu, Julie Wilhelmy, Peng Li, Linda Tannenbaum, Wenzhong Xiao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. An Overview of Severe Myalgic Encephalomyelitis.Journal of clinical medicine · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Oxidative stress is a shared characteristic of ME/CFS and Long COVID.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Translating insights into therapies for Long Covid.Science translational medicine · 2024
    Review
  12. Sex and disease severity-based analysis of steroid hormones in ME/CFS.Journal of endocrinological investigation · 2024
    Article
  13. Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Acquiring a new understanding of illness and agency: a narrative study of recovering from chronic fatigue syndrome.International journal of qualitative studies on health and well-being · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Chia-Jung ChangME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Li-Yuan HungME/CFS Collaborative Research Center at Harvard, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0002-0442-5829
Andreas M KogelnikBasis Diagnostics, Newark, CA 94560, USA.
David KaufmanME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Raeka S AiyarME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Angela M ChuME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Julie WilhelmyME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Peng LiME/CFS Collaborative Research Center at Harvard, Massachusetts General Hospital, Boston, MA 02114, USA.
Linda TannenbaumOpen Medicine Foundation, Agoura Hills, CA 91301, USA.ORCID 0000-0001-9885-4570
Wenzhong XiaoME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.ORCID 0000-0003-4944-6380
Ronald W DavisME/CFS Collaborative Research Center at Stanford, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Stanford University · USMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One in four myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients are estimated to be severely affected by the disease, and these house-bound or bedbound patients are currently understudied. Here, we report a comprehensive examination of the symptoms and clinical laboratory tests of a cohort of severely ill patients and healthy controls. The greatly reduced quality of life of the patients was negatively correlated with clinical depression. The most troublesome symptoms included fatigue (85%), pain (65%), cognitive impairment (50%), orthostatic intolerance (45%), sleep disturbance (35%), post-exertional malaise (30%), and neurosensory disturbance (30%). Sleep profiles and cognitive tests revealed distinctive impairments. Lower morning cortisol level and alterations in its diurnal rhythm were observed in the patients, and antibody and antigen measurements showed no evidence for acute infections by common viral or bacterial pathogens. These results highlight the urgent need of developing molecular diagnostic tests for ME/CFS. In addition, there was a striking similarity in symptoms between long COVID and ME/CFS, suggesting that studies on the mechanism and treatment of ME/CFS may help prevent and treat long COVID and vice versa.

Indexed as

antibody and antigenclinical symptomscognitive testslaboratory testslong COVIDpost-acute sequelae SARS-CoV-2 infection (PASC)quality of lifesevere ME/CFSsleepviral infection

Identifiers

PMID34682970
PMCPMC8535418
OpenAlexW3202812132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.